Clinical Results and Quality of Life Analysis for the Mvac Combination (Methotrexate, Vinblastine, Doxorubicin, and Cisplatin) in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study
AuthID
P-00V-T56
P-00V-T56